NDC 76489-001-01 - HemaCord
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76489-001
- Requested NDC
- 76489-001-01
- Package NDCs from labels
- 76489-001-01, 76489-001-02
- Manufacturer
- New York Blood Center | New York Blood Center, Inc.
- Effective date
- 2022-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HemaCord - New York Blood Center | New York Blood Center, Inc. | New York Blood Center | New York Blood Center, Inc. | 2022-10-19 | CELLULAR THERAPY |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76489-001-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-6f55-d83d-e063-dadaa90ab31f | These highlights do not include all the information needed to use HEMACORD safely and effectively. See full prescribing information for HEMACORD. HEMACORD (HPC, Cord Blood) Injectable Suspension for Intravenous Use Initial U.S. Approval: 2011 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76489-001-01 | HemaCord | 25 mL in 1 BAG | INJECTION | 25 | 9 | |
| 76489-001-02 | HemaCord | 1 in 1 CANISTER | INJECTION | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL | ACTIVE INGREDIENT | XU53VK93MC | HEMACORD (HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL) INJECTION [NEW YORK BLOOD CENTER] | 5 | |
| HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL | ACTIVE MOIETY | XU53VK93MC | HEMACORD (HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL) INJECTION [NEW YORK BLOOD CENTER] | 5 | |
| DIMETHYL SULFOXIDE | INACTIVE INGREDIENT | YOW8V9698H | HEMACORD (HUMAN CORD BLOOD HEMATOPOIETIC PROGENITOR CELL) INJECTION [NEW YORK BLOOD CENTER] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dimethyl Sulfoxide | DIMETHYL SULFOXIDE | Renova Pharmaceuticals LLC | 8f699de6-9d09-48da-9d95-4001d7008587 | 2026-07-20 | Warnings, Adverse reactions | YOW8V9698H |
| eb63d261-e74f-f8fa-e053-2a95a90a538a | bd9a5180-1773-11e0-980a-0002a5d5c51b | 2022-10-19 | Boxed warning, Warnings, Adverse reactions | eb63d261-e74f-f8fa-e053-2a95a90a538a bd9a5180-1773-11e0-980a-0002a5d5c51b | ||
| RIMSO-50 | DIMETHYL SULFOXIDE | Mylan Institutional LLC | 58b25d79-78f2-4953-b0c6-61658dc4ef0d | 2021-03-17 | Warnings, Adverse reactions | YOW8V9698H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.